NIPRIDE Trademark

Trademark Overview

On Thursday, March 17, 2016, a trademark application was filed for NIPRIDE with the United States Patent and Trademark Office. The USPTO has given the NIPRIDE trademark a serial number of 86943618. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, January 5, 2024. This trademark is owned by Exela Innovations. The NIPRIDE trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of hypertension
nipride

General Information

Serial Number86943618
Word MarkNIPRIDE
Filing DateThursday, March 17, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, January 5, 2024
Registration Number5242417
Registration DateTuesday, July 11, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 13, 2016

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of hypertension

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 22, 2016
Primary Code005
First Use Anywhere DateTuesday, March 28, 2017
First Use In Commerce DateTuesday, March 28, 2017

Trademark Owner History

Party NameExela Innovations
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645
Party NameExela Innovations
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645
Party NameExela Innovations
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLenoir, NC 28645

Trademark Events

Event DateEvent Description
Friday, January 5, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, January 5, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, January 5, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 11, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, July 11, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, June 6, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, June 5, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, June 3, 2017STATEMENT OF USE PROCESSING COMPLETE
Monday, May 8, 2017USE AMENDMENT FILED
Wednesday, May 31, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 8, 2017TEAS STATEMENT OF USE RECEIVED
Wednesday, March 29, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 29, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 13, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 13, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 24, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 10, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 4, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 29, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 29, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 21, 2016ASSIGNED TO LIE
Thursday, July 14, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 29, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 29, 2016NON-FINAL ACTION E-MAILED
Wednesday, June 29, 2016NON-FINAL ACTION WRITTEN
Tuesday, June 28, 2016ASSIGNED TO EXAMINER
Tuesday, March 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 21, 2016NEW APPLICATION ENTERED

Related Keywords

nipride hypertension treatment preparations pharmaceutical